Grace Therapeutics Statistics

Total Valuation

GRCE has a market cap or net worth of $41.07 million. The enterprise value is $18.66 million.

Market Cap	41.07M
Enterprise Value	18.66M

Important Dates

The last earnings date was Monday, June 23, 2025, before market open.

Earnings Date	Jun 23, 2025
Ex-Dividend Date	n/a

Share Statistics

GRCE has 13.83 million shares outstanding. The number of shares has increased by 26.85% in one year.

Current Share Class	13.83M
Shares Outstanding	13.83M
Shares Change (YoY)	+26.85%
Shares Change (QoQ)	+20.20%
Owned by Insiders (%)	18.50%
Owned by Institutions (%)	11.06%
Float	7.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.61
P/TBV Ratio	2.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.77

Current Ratio	11.77
Quick Ratio	11.53
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -14.91% and return on invested capital (ROIC) is -16.24%.

Return on Equity (ROE)	-14.91%
Return on Assets (ROA)	-14.35%
Return on Invested Capital (ROIC)	-16.24%
Return on Capital Employed (ROCE)	-23.80%
Revenue Per Employee	n/a
Profits Per Employee	-$299,000
Employee Count	32
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-3.20M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.91
52-Week Price Change	n/a
50-Day Moving Average	2.79
200-Day Moving Average	n/a
Relative Strength Index (RSI)	53.70
Average Volume (20 Days)	53,814

Short Selling Information

The latest short interest is 14,633, so 0.11% of the outstanding shares have been sold short.

Short Interest	14,633
Short Previous Month	14,096
Short % of Shares Out	0.11%
Short % of Float	0.19%
Short Ratio (days to cover)	0.42

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-16.68M
Pretax Income	n/a
Net Income	-9.57M
EBITDA	-16.67M
EBIT	-16.68M
Earnings Per Share (EPS)	-$0.79

Full Income Statement

Balance Sheet

The company has $22.13 million in cash and n/a in debt, giving a net cash position of $22.13 million or $1.60 per share.

Cash & Cash Equivalents	22.13M
Total Debt	n/a
Net Cash	22.13M
Net Cash Per Share	$1.60
Equity (Book Value)	66.61M
Book Value Per Share	4.86
Working Capital	20.78M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-14.90M
Capital Expenditures	n/a
Free Cash Flow	-14.90M
FCF Per Share	-$1.08

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GRCE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.85%
Shareholder Yield	-26.85%
Earnings Yield	-23.46%
FCF Yield	-36.54%

Analyst Forecast

The average price target for GRCE is $12.00, which is 304.04% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.00
Price Target Difference	304.04%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-5.20%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 10, 2023. It was a reverse split with a ratio of 0.1666667:1.

Last Split Date	Jul 10, 2023
Split Type	Reverse
Split Ratio	0.1666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a